FDA Pre-Submission Meeting Preparation Checklist for Pharmaceutical Companies
An FDA pre-submission meeting is a valuable opportunity for pharmaceutical companies to engage with regulators before submitting an application. These meetings help clarify regulatory expectations, address development challenges, and reduce the risk of delays during the review process.
What is Regulatory Strategy?
In the pharmaceutical industry, regulatory compliance is essential for bringing safe and effective products to market. Regulatory strategy is a planned approach that guides companies through regulatory requirements, submission pathways, and approval processes.
What is eCTD Viewer?
The pharmaceutical industry generates thousands of regulatory documents throughout the drug development and approval process. Managing, reviewing, and navigating these submissions efficiently is critical for regulatory success.
US FDA Issues New Guidance on ANDA Post-Approval Requirements (June 2026)
The U.S. FDA has issued a new guidance document titled “Certain Post-Approval Requirements and Resources for ANDAs” with the objective of streamlining ANDA approval communications.
Navigating Medical Device Regulations: The Strategic Role of an Indian Authorized Agent (IAA)
The medical device industry operates within a highly regulated environment where patient safety, product quality, and regulatory compliance are top priorities. For foreign manufacturers planning to enter the Indian market, navigating the country’s evolving regulatory framework can be complex.